/Investor DB

Ambit Health Ventures — 2024 Investments

3 investments dated 2024 · listed companies and verified rows first · show all

Encapsulateencapsulate.bioinSeed · Jun 2024 · $2M✓ verified

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days.

BiotechHealthtechMedical Devices

Armin Rad(Co-founder & CEO)inLeila Daneshmandi(Co-founder & COO)inBret Schipper(CMO)inJohn Strahley(CFO)in

Co-investorsConnecticut InnovationsBlackwood Healthcare Breakthroughs

Surgiboxsurgibox.comin𝕏Aug 2024

SurgiBox develops surgical technology co-developed with users to enable safe surgery for patients and healthcare providers, focused on delivering safe surgical care regardless of location.

BiotechHardwareHealthtechMedical DevicesCambridge, US

Debbie Teodorescu(Founder & Board Member)inKelly Laurel(CEO)inAtif Rakin(CTO)inKaren Pinto(VP)inMike Teodorescu(Co-Founder & Board Member)inJulian Greene(Executive Officer)

Board seatSam Goldberger· per SEC Form D

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Hubble Therapeutics, LLC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.